0 citations
The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
2020
Citations Over Time
Abstract
Continuous glucose monitoring (CGM) provides comprehensive assessment of daily glucose measurements for patients with diabetes and can reveal high and low blood glucose values that may occur even when a patient’s A1C is adequately controlled. Among the measures captured by CGM, the percentage of time in the target glycemic range, or “time in range,” (typically 70–180 mg/dL) has emerged as one of the strongest indicators of good glycemic control. This review examines the shift to using CGM to assess glycemic control and guide diabetes treatment decisions, with a focus on time in range as the key metric of glycemic control.
Related Papers
- → Indices for Assessment of the Quality of Glycemic Control and Glucose Dynamics from Continuous Glucose Monitoring(2017)4 cited
- → Continuous Glucose Monitoring and Glycemic Variability(2018)2 cited
- → Using Continuous Glucose Monitoring for Diabetes Mellitus in Pregnancy(2018)1 cited
- → The Effects of Exercise in Type 2 Diabetes as Measured by Continuous Glucose Monitoring: A Systematic Review and Meta-analysis(2012)
- → Response to Letter to the Editor from McKee and McGill: “Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring”(2021)